Rubicon Research Private Limited recalls AcetaZOLAMIDE Tablets
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Discoloration
- Products
-
- AcetaZOLAMIDE Tablets
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 3,984 bottles
- About this recall
- AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01